发明授权
- 专利标题： S1P receptors modulators and their use thereof
- 专利标题（中）： S1P受体调节剂及其用途
-
申请号： US14066276申请日： 2013-10-29
-
公开(公告)号： US09193716B2公开(公告)日： 2015-11-24
- 发明人: Gurmit S. Gill , Damian W. Grobelny
- 申请人： Akaal Pharma Pty Ltd.
- 申请人地址： AU Bundoora
- 专利权人： Akaal Pharma PTY LTD.
- 当前专利权人： Akaal Pharma PTY LTD.
- 当前专利权人地址： AU Bundoora
- 代理机构： Cooley LLP
- 代理商 Heidi A. Erlacher; Lian Ouyang
- 优先权： AU2008905369 20081017; AU2009903644 20090805
- 主分类号： A61K31/00
- IPC分类号： A61K31/00 ; C07D413/04 ; A61K31/16 ; A61K31/18 ; A61K31/343 ; A61K31/382 ; A61K31/397 ; A61K31/403 ; A61K31/41 ; A61K31/4164 ; C07C33/26 ; C07C215/10 ; C07C215/14 ; C07C215/16 ; C07C229/16 ; C07C275/24 ; C07C275/28 ; C07C281/06 ; C07D205/04 ; C07D209/04 ; C07D209/08 ; C07D215/18 ; C07D233/32 ; C07D241/12 ; C07D257/04 ; C07D295/104 ; C07D307/79 ; C07D307/81 ; C07D311/22 ; C07D333/04 ; C07D333/20 ; C07D413/10 ; C07D413/14 ; C07F9/09 ; C07F9/6558
摘要：
The invention relates to novel compounds that have SIP receptor modulating activity. Further, the invention relates to a pharmaceutical comprising at least one compound of the invention for the treatment of diseases and/or conditions caused by or associated with inappropriate SIP receptor modulating activity or expression, for example, autoimmune response. A further aspect of the invention relates to the use of a pharmaceutical comprising at least one compound of the invention for the manufacture of a medicament for the treatment of diseases and/or conditions caused by or associated with inappropriate SIP receptor modulating activity or expression such as autoimmune response.
公开/授权文献
- US20140066427A1 S1P Receptors Modulators and Their Use Thereof 公开/授权日：2014-03-06
信息查询
